ANAVO THERAPEUTICS
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications
ANAVO THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2020-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.anavotx.com
Total Employee:
1+
Status:
Active
Total Funding:
28.5 M EUR
Technology used in webpage:
Domain Not Resolving CrUX Top 50m CrUX Dataset Pound Sterling Amazon Route 53
Similar Organizations
Ajax Therapeutics
Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bioqube Ventures
Bioqube Ventures investment in Seed Round - Anavo Therapeutics
Inkef
Inkef investment in Seed Round - Anavo Therapeutics
M Ventures
M Ventures investment in Seed Round - Anavo Therapeutics
Taiho Ventures
Taiho Ventures investment in Seed Round - Anavo Therapeutics
MRL Ventures Fund
MRL Ventures Fund investment in Seed Round - Anavo Therapeutics
M Ventures
M Ventures investment in Seed Round - Anavo Therapeutics
Bioqube Ventures
Bioqube Ventures investment in Seed Round - Anavo Therapeutics
Taiho Ventures
Taiho Ventures investment in Seed Round - Anavo Therapeutics
Inkef
Inkef investment in Seed Round - Anavo Therapeutics
Official Site Inspections
http://www.anavotx.com Semrush global rank: 6.07 M Semrush visits lastest month: 1.13 K
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Anavo Therapeutics"
8-16-21 - Anavo to Establish R&D Hub in World ... - Anavo …
Aug 16, 2021 Leiden, The Netherlands, and Heidelberg, Germany, August 16, 2021 – Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of human phosphatase …See details»
12-9-21-Anavo Therapeutics Announces the Appointment of …
Dec 9, 2021 Leiden, The Netherlands, and Heidelberg, Germany, December 09, 2021 – Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of human phosphatase …See details»
Anavo Therapeutics BV - LinkedIn
Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades.See details»
Anavo Therapeutics–McDermott C: board, 202112– Board …
Dec 9, 2021 Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures and Bioqube Ventures. For more information, please visit: www.anavotx.com CONTACTS …See details»
Anavo Therapeutics Appoints Dr. Edward Holson as Chief Scientific ...
Oct 9, 2024 Anavo is backed by blue-chip investors M Ventures, an affiliate of Merck KGaA, Darmstadt, Germany, INKEF Capital, Taiho Ventures, MRL Ventures Fund, and Bioqube …See details»
Anavo Therapeutics Announces the Appointment of Charles …
Dec 9, 2021 Anavo Therapeutics Dr. Birgit Zech Chief Executive Officer +49 179 5340884 [email protected] Media Matthew Corcoran and Amanda Houlihan MacDougall +1 781 …See details»
Anavo Therapeutics B.V.. (8/16/21). "Press Release: Anavo …
For more information, please visit: www.anavotx.com CONTACTS Avavo Therapeutics Dr. Birgit Zech Chief Executive Officer +49 179 5340884 [email protected] Media Contact Mario …See details»
Anavo Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Anavo Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Anavo Therapeutics Launches with EUR 20 Million Seed …
Apr 22, 2021 Avavo Therapeutics Dr. Birgit Zech Chief Executive Officer +49 179 5340884 [email protected] Media Contact Mario Brkulj and Amanda Houlihan MacDougall +49 175 5711562 or +1 781-235-3060 anavotx ...See details»
9.21.23 – Anavo Therapeutics Strengthens Management Team
For more information, please visit: www.anavotx.com. CONTACTS. Anavo Therapeutics Dr. Birgit Zech Chief Executive Officer +49 179 5340884 [email protected]. Media Contact Chelsea …See details»
Anavo Therapeutics Appoints Dr. Edward Holson as Chief Scientific ...
Oct 9, 2024 LEIDEN, Netherlands, October 09, 2024--Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of phosphatase biology, today announced the …See details»
Anavo Therapeutics to Establish R&D Hub in World-Leading …
Aug 16, 2021 Back to the news overview. Anavo Therapeutics to Establish R&D Hub in World-Leading Cancer Research Cluster. Leiden, The Netherlands, and Heidelberg, Germany, …See details»
6-24-21 - Anavo Strengthens Scientific Advisory Board - Anavo …
Jun 24, 2021 For more information, please visit: www.anavotx.com . CONTACTS. Avavo Therapeutics Dr. Birgit Zech Chief Executive Officer +49 179 5340884 [email protected]. …See details»
Anavo Therapeutics Launches with EUR 20 Million Seed Financing …
Apr 22, 2021 For more information, please visit: www.anavotx.com. About M Ventures. M Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in …See details»
Anavo Therapeutics Strengthens Scientific Advisory Board with …
Jun 24, 2021 Avavo Therapeutics Dr. Birgit Zech Chief Executive Officer +49 179 5340884 [email protected] Media Contact Mario Brkulj and Amanda Houlihan MacDougall +49 175 …See details»
Anavo Therapeutics extends Seed Round to EUR 28 Million to …
May 2, 2023 LEIDEN, The Netherlands & HEIDELBERG, Germany--(BUSINESS WIRE)--Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of human phosphatase …See details»
Anavo Therapeutics extends Seed Round to EUR 28 Million to …
May 2, 2023 Anavo Therapeutics Dr. Birgit Zech Chief Executive Officer +49 179 5340884 [email protected]. Media Contact Chelsea Rule MacDougall Advisors +1 781-235-3060 …See details»
Privacy Statement - Anavo Therapeutics
- Organization - Language. Our processing basis is our legitimate interest to be able to respond to your questions and requests and to be able to improve our services and the website. D. If you …See details»
4-22-21-Anavo Therapeutics Launches with EUR 20 Million Seed …
Apr 22, 2021 Leiden, The Netherlands, April 22, 2021 – Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of human phosphatase biology, debuted today with a …See details»